1. Agrawal, K., Das, V., Vyas, P., & Hajduch, M. (2018). Nucleosidic DNA demethylating epigenetic drugs—A comprehensive review from discovery to clinic. Pharmacology & therapeutics. pii: S0163,
7258(18), 30031–30037.
2. Ali, O., Cerjak, D., Kent, J. W., Jr., James, R., Blangero, J., Carless, M. A., et al. (2015). An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome. Clinical Epigenetics,
7(12), 1–18.
3. Allis, C. D., & Jenuwein, T. (2016). The molecular hallmarks of epigenetic control. Nature Reviews Genetics,
18(8), 487–500.
4. Anway, M. D. (2005). Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science,
308(5727), 1466–1469.
5. Arksey, H., & O’Malley, L. (2005). Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology,
8(1), 19–32.